Oura, the maker of smart rings, announced on Tuesday that it will acquire Counsel Health, an AI-native primary care company, in a deal valued at $625 million. This acquisition comes shortly after Oura indefinitely postponed its planned Initial Public Offering, which was valued at up to $2.2 billion, citing uncertainty in the current market environment.
Counsel Health operates an AI-powered platform that integrates chat-based medical experiences with access to licensed physicians. The service was first integrated into the Oura app in June 2026, allowing users to receive personalized medical advice and consult with doctors directly within the application. Following the acquisition, the two companies plan to expand their partnership to cover preventative, acute, and specialty chronic care.
As competition in the smart ring market intensifies from rivals such as RingConn and Ultrahuman, Oura is leveraging this deal to broaden its business model and enhance user engagement. Tom Hale, Oura’s Chief Executive Officer, stated in a press release that the combination allows members to take action on their health needs, ranging from simple questions and prescriptions to lab results and referrals. “Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs,” Hale said.
Counsel Health had previously raised a $25 million Series A funding round led by Andreessen Horowitz and GV. Pitchbook estimates indicate that the startup had raised a total of $36 million to date. Post-acquisition, Counsel will continue to serve its existing and new enterprise partners with the goal of extending its AI-native care model beyond Oura’s membership base.
Muthu Alagappan, the Chief Executive Officer of Counsel Health, will join Oura as the Chief Clinical AI Officer. He will bring with him a team of approximately 70 employees. Alagappan emphasized that the company built its medical AI with a focus on trust, safety, and physician involvement in clinical decisions. “Oura’s data gives clinicians objective context, trended biometrics, and member engagement to deliver more informed care,” Alagappan noted.
The acquisition is expected to close before the end of 2027. In related financial news, Oura reported that its revenue increased by 153% year-over-year to $533 million for the quarter ended September 30. For fiscal year 2026, the company generated approximately $1.75 billion in revenue, representing a 92% year-over-year growth. Oura had reached an $11 billion valuation following a $900 million late-stage funding round in October 2025.
Curious if Counsel will remain independent for enterprise clients or get fully absorbed into the Oura ecosystem.
They postponed the IPO for this? Seems like a risky move to burn that much cash on acquisition.
Putting a ring on your finger for primary care feels like a massive leap for healthcare accessibility.